There are over 700 biotechs and trade sources say only about 2.5% have any deal in year -- that's a low probability of a biotech having a deal and certainly not an OTC biotech penny stock. Haven't found a single OTC biotech penny stock doing a BP deal in the last decade. So if a BP deal is a NWBO investment thesis, the odds say it is highly unlikely.
and everyone claiming BO at the end of last year was out of their mind.